| 441 |
CALSOURCE CA-C 1000 ORANGE |
ASCORBIC ACID 1 G, CALCIUM LACTATE GLUCONATE 1 G, CALCIUM CARBONATE 327 MG |
EFFERVESCENT TABLET |
TUBE |
CALCIUM AND VITAMIN C ARE ESSENTIAL ESPECIALLY IN DEVELOPMENT OF HEALTHY BONE AND TEETH, AND IN PREGNANCY AND LACTATION FOR CALCIUM AND VITAMIN C SUPPLEMENT. |
NULL |
DKSH LAOS COMPANY LIMITED |
DELPHARM ORLEANS |
SWITZERLAND |
CERTIFICATE RELEASED |
01 I 2873/07 |
08-APR-2024 |
07-APR-2027 |
View |
| 442 |
CANESTEN |
CLOTRIMAZOLE PH.EUR 1 % W/W |
CREAM |
TUBE |
TREATMENT OF SKIN INFECTION CAUSED BY DERMATOPHYTES, YEASTS, MOULDS AND FUNGI (E.G. TINEA PEDIS, TINEA MANUUM, TINEA CORPORIS, TINEA INGUINALIS, PITYRIASIS VERSICOLOR. TREATMENT OF ERYTHRASMA AND FEMALE FUNGAL INFECTION OF THE VAGINAL AREA, IT CAN ALSO BE USED IN MALES WHERE INFLAMMATION IS PRESENT IN THE PENIS CAUSED BY YEAST, FUNGI (CANDIDA VULVITIS AND CANDIDA BALANITIS) |
NULL |
DKSH LAOS COMPANY LIMITED |
ENCUBE ETHICALS PRIVATE LIMITED |
INDIA |
CERTIFICATE RELEASED |
04 I 5898/25 |
07-APR-2025 |
06-APR-2030 |
View |
| 443 |
CANESTEN |
CLOTRIMAZOLE 100 MG |
VAGINAL TABLET |
ALUMINIUM FOIL |
INFECTION OF THE GENITAL REGION (VAGINITIS) CAUSED BY FUNGI (USUALLY CANDIDA) AND SUPRAINFECTIONS CAUSED BY CLOTRIMAZOLE-SENSITIVE BACTERIA. |
NULL |
DKSH LAOS COMPANY LIMITED |
HAUPT PHARMA WULFING GMBH |
GERMANY |
CERTIFICATE RELEASED |
04 I 4417/18 |
28-APR-2023 |
27-APR-2026 |
View |
| 444 |
CANESTEN 1 |
CLOTRIMAZOLE 500 MG |
VAGINAL TABLET |
ALUMINIUM FOIL |
INFECTIOUS LEUCORRHEA, VAGINITIS AND ITCHING CAUSED BY FUNGI-MOSTLY CANDIDA AND/OR TRICHOMONAS SUPRAINFECTIONS CAUSED BY CANESTEN-SENSITIVE BACTERIA. |
NULL |
DKSH LAOS COMPANY LIMITED |
HAUPT PHARMA WULFING GMBH |
GERMANY |
CERTIFICATE RELEASED |
06 I 4475/18 |
28-APR-2023 |
27-APR-2026 |
View |
| 445 |
CANESTEN OD |
BIFONAZOLE 1% |
CREAM |
TUBE |
TREATMENT OF SKIN MYCOSES CAUSED BY DERMATOPHYTES, YEASTS, MOULDS AND OTHER FUNGI (E.G. TINEA PEDIS, TINEA MANUUM, TINEA CORPORIS, TINEA INGUINALIS, PITYRIASIS VERSICOLOR, SUPERFICIAL CANDIDIASIS). TREATMENT OF ERYTHRASMA. |
NULL |
DKSH LAOS COMPANY LIMITED |
KERN PHARMA, S.L. |
SPAIN |
CERTIFICATE RELEASED |
06 I 4476/18 |
07-JUN-2023 |
06-JUN-2026 |
View |
| 446 |
CANESTEN OD |
BIFONAZOLE 1% |
CREAM |
TUBE |
FOR TREATMENT OF SKIN MYCOSES CAUSED BY DERMATOPHYTES, YEASTS, MOULDS, AND OTHER FUNGI (E.G. TINEA PEDIS, TINEA MANUUM, TINEA CORPORIS, TINEA INGUINALIS, PITYRIASIS VERSICOLOR, SUPERFICIALCANDIDIASIS), TREATMENT OF ERYTRASMA. |
NULL |
DKSH LAOS COMPANY LIMITED |
GP GRENZACH PRODUKTIONS GMBH |
GERMANY |
CERTIFICATE RELEASED |
05 I 5744/24 |
24-MAY-2024 |
23-MAY-2027 |
View |
| 447 |
CEFTAZEX 1000 |
CEFTAZIDIME PENTAHYDRATE BP EQ.TO CEFTAZIDIME 1 G |
POWDER FOR SOLUTION FOR INJECTION |
VIAL |
NOSOCOMIAL PNEUMONIA, BRONCHO-PULMONARY INFECTION IN CYSTIC FIBROSIS, BACTERIAL MENINGITIS, CHRONIC SUPPURATIVE OTITIS MEDIA, MALIGNANT OTITIS MEDIA, COMPLICATED URINARY TRACT INFECTION, COMPLICATED SKIN AND SOFT TISSUE INFECTION, BONE AND JOINT INFECTION |
NULL |
DKSH LAOS COMPANY LIMITED |
COTEC HEALTHCARE PVT LTD |
INDIA |
CERTIFICATE RELEASED |
12 I 5337/22 |
30-DEC-2022 |
29-DEC-2025 |
View |
| 448 |
CEFTEC 1000 |
CEFTRIAXONE SODIUM STERILE USP EQ.TO CEFTRIAXONE 1000 MG |
POWDER FOR SOLUTION FOR INJECTION |
VIAL |
FOR THE TREATMENT OF BACTERIAL MENINGITIS, COMMUNITY ACQUIRED PNEUMONIA, ACUTE OTITIS MEDIA, INTRA-ABDOMINAL INFECTION, COMPLICATED URINARY TRACT INFECTION, INFECTION OF BONES AND JOINTS, COMPLICATED SKIN AND SOFT TISSUE INFECTION, GONORRHEA, SYPHILIS AND BACTERIAL ENDOCARDITIS |
NULL |
DKSH LAOS COMPANY LIMITED |
COTEC HEALTHCARE PVT LTD |
INDIA |
CERTIFICATE RELEASED |
12 I 5338/22 |
30-DEC-2022 |
29-DEC-2025 |
View |
| 449 |
CELLCEPT 500MG |
MYCOPHENOLATE MOFETIL 500MG |
FILM-COATED TABLETS |
BLISTERPACK |
PROPHYLAXIS OF ACUTE ORGAN REJECTION AND FOR THE TREATMENT OF FIRST OR REFRACTORY ORGAN REJECTION IN PATIENTS RECEIVING ALLOGENEIC RENAL TRANSPLANTS; FOR THE PROPHYLAXIS OF ACUTE ORGAN REJECTION IN PATIENTS RECEIVING ALLOGENEIC CARDIAC AND HEPATIC TRANSPLANTS |
NULL |
DKSH LAOS COMPANY LIMITED |
DELPHARM MILANO S.R.L. |
ITALY |
CERTIFICATE RELEASED |
07 I 2309/04 |
22-APR-2025 |
21-APR-2030 |
View |
| 450 |
OME - CAP |
OMEPRAZOLE 20 MG |
CAPSULE |
BLISTERPACK |
ADULTS : TREATMENT OF DUODENAL ULCER, INCLUDING PREVENTION OF RELAPSE GASTRICT ULCER AND REFLUX OESOPHAGITIS.
SYMPTOMATIC RELIEF OF HEARTBURN IN PATIENTS WITH GASTRO - OESOPHAGEAL REFLUX DISEASE (GORD) AND THE SHORT - TERM RELIEF OF FUNCTIONAL DYSPEPSIA, LONG TERM MANAGEMENT OF REFLUX OESOPHAGITIS AND ZOLLINGER-ELLISON SYNDROME |
NULL |
CBF PHARMA CO.,LTD |
JIANGSU RUINIAN QIANJIN PHARMACEUTICAL CO.,LTD |
CHINA |
STEP 1: RECEIVE (RENEW) |
05 I 4268/17 |
15-JUN-2021 |
14-JUN-2024 |
View |
